PUBLISHER: The Business Research Company | PRODUCT CODE: 1097925
PUBLISHER: The Business Research Company | PRODUCT CODE: 1097925
Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035
Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 8 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
Where is the largest and fastest growing market for the animal testing and non-animal alternative testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The animal testing and non-animal alternative testing market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider animal testing and non-animal alternative testing market; and compares it with other markets.
The report covers the following chapters:
Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
Report Structure - This section gives the structure of the report and the information covered in the various sections.
Introduction - This section gives the segmentation of the animal testing and non-animal alternative testing market by geography and by type covered in this report.
Market Characteristics - This section introduces the market and provides information on market definitions of animal testing and non-animal alternative testing markets.
Market Value Chain Analysis - This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets.
Non-Animal Alternative Testing Trends - This chapter describes the major trends shaping the global non-animal alternative testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Cost Analysis For Animal Testing and Alternative Technologies - This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods.
Animal Testing And Non-Animal Alternative Testing By Type And End Use - This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies.
End-User Industries Adoption To Alternative Technologies - This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe.
Global Animal Testing Market Size - This section provides information on the global animal testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
Global Non-Animal Alternative Testing Market Size - This section provides information on the global non-animal alternative testing market size for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
Animal Testing And Non Animal Testing Market Regional And Country Analysis - This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies.
Animal Testing Regulatory Landscape - This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies.
Competitive Landscape For Alternative Technologies - This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies.
Market Opportunities And Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for animal testing and non-animal alternative testing providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By End User Industry: Pharmaceuticals; Academic Research; Medical Devices; Chemicals And Pesticides; Cosmetics; Others
2) By Animal Type: Mice; Rat; Frogs; Fish; Birds; Guinea pig; Hamster; Rabbits; Sheep; Dogs; Cats; Monkeys; Pigs; Others
Companies Mentioned: Cyprotex; Bio-Rad Laboratories, Inc.; MatTek Corporation; Emulate, Inc; BioIVT
Countries: Australia; China; France; Germany; Japan; UK; USA; Canada
Regions: Asia-Pacific; Europe; North America; Rest Of The World
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Animal Testing And Non-Animal Alternative Testing Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
- 6.1. Segmentation By Geography
- 6.2. Segmentation By End User Industry
7. Animal Testing And Non-Animal Alternative Testing Market Characteristics
- 7.1.1. Animal Testing
- 7.1.2. Non-Animal Alternative Testing
- 7.1.3. Facts About Animals In Research - Functional Resemblances Of Animals To Human Body
- 7.2. Animal Testing And Non-Animal Alternative Testing Market Segmentation By End-Use Industry
- 7.2.1. Pharmaceutical Industry
- 7.2.2. Academic Industry
- 7.2.3. Medical Devices
- 7.2.4. Chemicals And Pesticides Industry
- 7.2.5. Cosmetics
- 7.2.6. Others
8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis
- 8.1.1. Animal Breeders and Suppliers
- 8.1.2. Non-Animal Alternative Testing Technology Developers
- 8.1.3. Regulatory Authorities
- 8.1.4. Alternative Testing Service Providers
- 8.1.5. End-Use Industries
9. Non-Animal Alternative Testing Trends
- 9.1. Development In OOC (organ-on-chip) For Testing
- 9.2. Adoption Of Human Patient Simulators For Testing
- 9.3. Focus On Development Of 3D-Printed Organs For Testing
10. Cost Analysis For Animal Testing And Alternative Technologies
- 10.1.1. Average Cost Of Laboratory Animals
- 10.1.2. Average Cost Of Non-Animal Alternative Testing Methods
- 10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
- 10.2. Costs Involved In Animal Testing, 2021
11. Animal Testing And Non-Animal Alternative Testing Market Segments
- 11.1. By End Use Industrial Application
- 11.1.1. Important Areas of Use
- 11.1.2. Basic Research
- 11.1.3. Applied Research
- 11.1.4. Regulatory Testing
- 11.1.5. Development Of New Diagnostic Methods
- 11.1.6. Breeding Of Genetically Altered Animals
- 11.1.7. Animal Cloning
- 11.1.8. End-User Applications
- 11.2. Animal Testing Market By Animal Type
- 11.2.1. Mice
- 11.2.2. Rat
- 11.2.3. Frogs
- 11.2.4. Fish
- 11.2.5. Birds
- 11.2.6. Guinea pig
- 11.2.7. Hamster
- 11.2.8. Rabbits
- 11.2.9. Sheep
- 11.2.10. Dogs
- 11.2.11. Cats
- 11.2.12. Monkeys
- 11.2.13. Pigs
- 11.2.14. Others
12. Number Of Animals Used In Research, By Country
- 12.1.1. USA
- 12.1.2. Europe
- 12.1.3. United Kingdom (UK)
- 12.1.4. Germany
- 12.1.5. France
- 12.1.6. Australia
- 12.1.7. Canada
- 12.1.8. China
13. Non-Animal Alternative Testing Technologies By Type And End Use
- 13.1. Introduction
- 13.2. Types Of Non-Animal Alternative Testing Technologies
- 13.2.1. Cell Or Tissue Culture (In-Vitro)
- 13.2.2. Major Cell Culture Developers Worldwide
- 13.2.3. Organ-On-Chip (OOC)
- 13.2.4. Global OOC Market Size And Growth
- 13.2.5. Global OOC Market Drivers And Restraints
- 13.2.6. Market Drivers
- 13.2.7. Market Restraints
- 13.2.8. In-silico (Computer-Based Models)
- 13.2.9. Artificial Skin Models (Skin Substitutes)
- 13.2.10. Other Technologies
14. End-User Industries Adoption To Alternative Testing Technologies
- 14.1.Adoption of Alternative Testing Technologies By Type of Industry
- 14.1.1. Cosmetics Industry
- 14.1.2. Pharmaceutical Industry
- 14.1.3. Medical Device Industry
- 14.1.4. Others
- 14.2. Adoption of 3R's In USA
- 14.2.1. 3R Adoption In The Cosmetics Industry
- 14.2.2. 3R Adoption In The Pharmaceutical Industry
- 14.2.3. 3R Adoption In The Medical Device Industry
- 14.3.Adoption of 3R's In China
- 14.3.1. 3R Adoption In The Cosmetics Industry
- 14.3.2. 3R Adoption In The Pharmaceutical Industry
- 14.3.3. 3R Adoption In The Medical Device Industry
- 14.4. Adoption of 3R's In Europe
- 14.4.1. 3R Adoption In The Cosmetics Industry
- 14.4.2. 3R Adoption In The Pharmaceutical Industry
- 14.4.3. 3R Adoption In The Medical Device Industry
15. Global Animal Testing And Non-Animal Testing Market
- 15.1. Global Animal Testing Market Size And Growth
- 15.1.1. Global Animal Testing Market Value ($ Billion)
- 15.1.2. Global Animal Testing Market, By Volume (Million Units)
- 15.1.3. Drivers Of The Animal Testing Market
- 15.1.4. Restraints On The Animal Testing Market
- 15.2. Global Non-Animal Alternative Testing Market Size And Growth
- 15.2.1. Global Non-Animal Alternative Testing Market Value ($ Billion)
- 15.2.2. Drivers Of The Non-Animal Alternative Testing Market
- 15.2.3. Restraints On The Non-Animal Alternative Testing Market
16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis
17. USA Animal Testing And Non-Animal Alternative Testing Market
- 17.1. USA Animal Testing Market
- 17.1.1. USA Animal Testing Market Value ($ Billion)
- 17.1.2. USA Animal Testing Market, By Volume (Million Units)
- 17.2. USA Non-Animal Alternative Testing Market
- 17.2.1. USA Non-Animal Alternative Testing Market Value ($ Billion)
- 17.3. USA Animal Testing Market By End Use Industrial Application
- 17.3.1. Market By Value And Volume
- 17.3.2. Pharmaceuticals
- 17.3.3. Academic Research industry was the second largest
- 17.3.4. Medical Devices industry was the third largest
- 17.3.5. Chemicals And Pesticides industry was the fourth largest
- 17.3.6. Cosmetics industry was the smallest
- 17.3.7. Other industries were the fifth largest
- 17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
- 17.4. Regulatory Landscape In The USA
- 17.4.1. Regulatory Bodies & Policies
- 17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
- 17.4.3. USDA & Animal Welfare Act
- 17.4.4. ICCVAM
- 17.4.5. FDA
- 17.4.6. NIH
18. Japan Animal Testing And Non-Animal Alternative Testing Market
- 18.1. Japan Animal Testing Market
- 18.1.1. Japan Animal Testing Market Value ($ Billion)
- 18.1.2. Japan Animal Testing Market, By Volume (Million Units)
- 18.2. Japan Non-Animal Alternative Testing Market
- 18.2.1. Japan Non-Animal Alternative Testing Market Value ($ Billion)
- 18.3.Japan Animal Testing Market By End Use Industrial Application
- 18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
- 18.4. Regulatory Landscape In Japan
- 18.4.1. Regulatory Bodies & Policies
- 18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
- 18.4.3. Law for the Humane Treatment and Management of Animals
- 18.4.4. MHLW, MEXT, And MAFF
19. China Animal Testing And Non-Animal Alternative Testing Market
- 19.1.China Animal Testing Market
- 19.1.1. China Animal Testing Market Value ($ Billion)
- 19.1.2. China Animal Testing Market, By Volume (Million Units)
- 19.2. Regulatory Landscape In China
- 19.2.1. Regulatory Bodies & Policies
- 19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
20. Australia Animal Testing And Non-Animal Alternative Testing Market
- 20.1. Australia Animal Testing Market
- 20.1.1. Australia Animal Testing Market Value ($ Billion)
- 20.1.2. Australia Animal Testing Market, By Volume (Million Units)
- 20.2. Regulatory Landscape In Australia
- 20.2.1. Regulatory Bodies & Policies
- 20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
21. Europe Animal Testing And Non-Animal Alternative Testing Market
- 21.1. Regulatory Landscape In Europe
- 21.1.1. EU Directive 2010/63
- 21.2. Europe Non-Animal Alternative Testing Market
- 21.2.1. Europe Non-Animal Alternative Testing Market Value ($ Billion)
22. France Animal Testing And Non-Animal Alternative Testing Market
- 22.1. France Animal Testing Market
- 22.1.1. France Animal Testing Market Value ($ Billion)
- 22.1.2. France Animal Testing Market, By Volume (Million Units)
- 22.2. France Animal Testing Market By End Use Industrial Application
- 22.2.1. Market By Value And Volume
- 22.2.2. Pharmaceuticals
- 22.2.3. Academic Research industry was the second largest
- 22.2.4. Chemicals & Pesticides industry was the third largest
- 22.2.5. Medical Devices industry was the fourth largest
- 22.2.6. Cosmetics industry was the smallest
- 22.2.7. Other industries were the fifth largest
- 22.3. Regulatory Landscape In France
- 22.3.1. Regulatory Bodies & Policies
- 22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
23. Germany Animal Testing And Non-Animal Alternative Testing Market
- 23.1. Germany Animal Testing Market
- 23.1.1. Germany Animal Testing Market Value ($ Billion)
- 23.1.2. Germany Animal Testing Market, By Volume (Million Units)
- 23.2. Germany Animal Testing Market By End Use Industrial Application
- 23.2.1. Market By Value And Volume
- 23.2.2. Pharmaceuticals
- 23.2.3. Academic Research industry was the second largest
- 23.2.4. Medical Devices industry was the third largest
- 23.2.5. Chemicals And Pesticides industry was the fifth largest
- 23.2.6. Cosmetics industry was the smallest
- 23.2.7. Other industries were the fifth largest
- 23.3.Regulatory Landscape In Germany
- 23.3.1. Regulatory Bodies & Policies
- 23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
24. UK Animal Testing And Non-Animal Alternative Testing Market
- 24.1. UK Animal Testing Market
- 24.1.1. UK Animal Testing Market Value ($ Billion)
- 24.1.2. UK Animal Testing Market, By Volume (Million Units)
- 24.2. UK Animal Testing Market By End Use Industrial Application
- 24.2.1. Market By Value And Volume
- 24.2.2. Pharmaceuticals
- 24.2.3. Academic Research industry was the second largest
- 24.2.4. Medical Devices industry was the third largest
- 24.2.5. Chemicals & Pesticides industry was the fifth largest
- 24.2.6. Cosmetics industry was the smallest
- 24.2.7. Other industries were the fourth largest
- 24.3. Regulatory Landscape in United Kingdom (UK)
- 24.3.1. Regulatory Bodies & Policies
- 24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
25. Canada Animal Testing And Non-Animal Alternative Testing Market
- 25.1. Canada Animal Testing Market
- 25.1.1. Canada Animal Testing Market Value ($ Billion)
- 25.1.2. Canada Animal Testing Market, By Volume (Million Units)
- 25.2. Regulatory Landscape In Canada
- 25.2.1. Regulatory Bodies & Policies
- 25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
- 26.1. Rest Of The World Animal Testing Market
- 26.1.1. Rest Of The World Animal Testing Market Value ($ Billion)
- 26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
- 26.2. Rest of The World Non-Animal Alternative Testing Market
- 26.2.1. Rest of The World Non-Animal Alternative Testing Market Value ($ Billion)
- 26.3. Regulatory Landscape In Rest of the World (RoW)
- 26.3.1. Regulatory Bodies & Policies
- 26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
27. Competitive Landscape For Non-Animal Alternative Technologies
- 27.1. Company Profiles
- 27.2. Cyprotex
- 27.2.1. Company Overview
- 27.2.2. Products And Services
- 27.2.3. Business Strategy
- 27.2.4. Financial Overview
- 27.3. Bio-Rad Laboratories, Inc.
- 27.3.1. Company Overview
- 27.3.2. Products And Services
- 27.3.3. Business Strategy
- 27.3.4. Financial Overview
- 27.4. MatTek Corporation
- 27.4.1. Company Overview
- 27.4.2. Products And Services
- 27.4.3. Business Strategy
- 27.4.4. Financial Overview
- 27.5.Emulate, Inc
- 27.5.1. Company Overview
- 27.5.2. Products And Services
- 27.5.3. Business Strategy
- 27.5.4. Financial Overview
- 27.6. BioIVT
- 27.6.1. Company Overview
- 27.6.2. Products And Services
- 27.6.3. Business Strategy
- 27.6.4. Financial Overview
- 27.7. USA Non-Animal Alternative Testing Market Competitive Landscape
- 27.7.1. Emulate, Inc
- 27.7.2. Organovo Holdings, Inc
- 27.7.3. MatTek Corporation
- 27.7.4. EMD Millipore
- 27.8. China Non-Animal Alternative Testing Market Competitive Landscape
- 27.8.1. China Tissue Engineering Co., Ltd. (J-TEC)
- 27.8.2. ReproCell Inc
- 27.8.3. Organ Technologies Co, Ltd
- 27.9. Europe Non-Animal Alternative Testing Market Competitive Landscape
- 27.9.1. Episkin
28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
- 28.1. Global Animal Testing Market In 2035 - Geographies Offering Most New Opportunities
- 28.2. Global Non-Animal Alternative Testing Market In 2035 - Geographies Offering Most New Opportunities
- 28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 - Segments Offering Most New Opportunities
- 28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2025 - Growth Strategies
- 28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
- 28.4.2. Competitor Strategies
29. Conclusions & Recommendations
- 29.1. Conclusions
- 29.2. Recommendations
- 29.2.1. Product
- 29.3. Develop 3D-Printed Organs
- 29.3.1. Price
- 29.3.2. Place
- 29.3.3. Promotion
- 29.3.4. People
- 29.3.5. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries
- 29.3.6. Increasing Number Of Players In The Non-Animal Alternative Testing Market
- 29.3.7. Focus On Developed Countries
- 29.3.8. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion
30. Appendix
- 30.1.Glossary
- 30.2. Market Data Sources
- 30.3.Research Methodology
- 30.3.1. OCED Accepted In Vito Tests
- 30.4. Survey on Animal Models & Testing Landscape in the US
- 30.4.1. Current Condition By Company
- 30.4.2. Number Of Animals Used In Testing
- 30.5. Expert Interviews List
- 30.6. Non Animal Alternative Testing Interviews
- 30.7. USA Interviews
- 30.7.1. Interview 1
- 30.7.2. Interview 2
- 30.7.3. Interview 3
- 30.7.4. Interview 4
- 30.7.5. Interview 5
- 30.7.6. Interview 6
- 30.7.7. Interview 7
- 30.7.8. Interview 8
- 30.7.9. Interview 9
- 30.8. China Interviews
- 30.8.1. Interview 10
- 30.8.2. Interview 11
- 30.8.3. Interview 12
- 30.8.4. Interview 13
- 30.8.5. Interview 14
- 30.8.6. Interview 15
- 30.9. Animal Testing Interviews
- 30.9.1. Interview 16
- 30.9.2. Interview 17
- 30.9.3. Interview 18
- 30.9.4. Interview 19
- 30.9.5. Interview 20
- 30.9.6. Interview 21
- 30.9.7. Interview 22
- 30.9.8. Interview 23
